Albert Friesen

Albert Friesen

Chief Executive Officer at MEDICURE INC.

Net worth: 2 M $ as of 31/05/2026

79 year
Health Technology
Finance
Commercial Services

Profile

Albert D.
Friesen
is the founder of Viventia Biotech, Inc. (founded 1995), Medicure, Inc. (founded 1997) where the title held is Chairman, President & Chief Executive Officer, Luminor Medical Technologies, Inc. (founded 1998) where the title held is Chairman, Winnipeg RH Institute Foundation, Inc. (founded 1971) where the title held is President, and Genesys Venture, Inc. (founded 1997) where the title held is President.
Dr. Friesen is also the founder of ABI Biotechnology, Inc.,Genesys Pharma, Inc.,KAM Scientific, Inc.,Industrial Biotechnology Association of Canada..
Dr. Friesen is Chief Executive Officer at CentreStone Ventures, Inc. since 2006.
Dr. Friesen is Chairman, President & Chief Executive Officer at Marsala Biotech Inc. Dr. Friesen is Co-Chairman at Manitoba Innovation Council.
Dr. Friesen is Chairman at Waverley Pharma, Inc. since 2016.
Dr. Friesen is Chairman & President at GVI Clinical Development Solutions, Inc. Dr. Friesen is Director at Mylan API, Inc. Dr. Friesen is Director at Magellan Biotech, Inc. Dr. Friesen is Director at Canada Foundation for Innovation since 2010.
Dr. Friesen is Director at Sensible Medical Innovations Ltd. since 2019.
Dr. Friesen was Chief Executive Officer & Director at Big Sky Petroleum Corp.
from 2006 to 2008.
Dr. Friesen was CEO, Secretary & Non-Independent Director at Buffalo Capital, Inc. Dr. Friesen was Chairman at Kane Biotech, Inc. from 2001 to 2011.
Dr. Friesen was Director at DiaMedica Therapeutics, Inc. from 2007 to 2008.
Dr. Friesen was Director at MEDA Investments, Inc. from 2000 to 2012.
Dr. Friesen was Director at Waverley Pharma, Inc. Dr. Friesen was Member-Industrial Advisory Committee at Biotechnology Research Corp.
Dr. Friesen earned a doctorate from the University of Manitoba.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/04/2026 2,580,827 ( 24.73% ) 2 M $ 31/05/2026
05/05/2025 40,292,000 ( 74.61% ) 282 044 $ 31/05/2026

Albert Friesen active positions

CompaniesPositionStart
MEDICURE INC. Chief Executive Officer 15/09/1997
WAVERLEY PHARMA INC. Chairman 14/12/2016
Chief Executive Officer 01/01/2006
Director/Board Member 29/01/2019
Director/Board Member -
Chief Executive Officer -
Manitoba Innovation Council
Chairman 20/05/2011
Director/Board Member 16/02/2010
Director/Board Member 25/11/2009
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░

Former positions of Albert Friesen

CompaniesPositionEnd
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Albert Friesen's experience

Training of Albert Friesen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies26

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Finance

Consumer Services

Finance

Commercial Services

Industrial Biotechnology Association of Canada

Finance

Miscellaneous

ABI Biotechnology, Inc.

Genesys Pharma, Inc.

Process Industries

Finance

Health Technology

Manitoba Innovation Council

Energy Minerals

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Albert Friesen
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!